These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 10439174)

  • 21. Regional cerebral blood flow imaging: a quantitative comparison of technetium-99m-HMPAO SPECT with C15O2 PET.
    Gemmell HG; Evans NT; Besson JA; Roeda D; Davidson J; Dodd MG; Sharp PF; Smith FW; Crawford JR; Newton RH
    J Nucl Med; 1990 Oct; 31(10):1595-600. PubMed ID: 2120397
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Brain perfusion SPECT with an automated quantitative tool can identify prodromal Alzheimer's disease among patients with mild cognitive impairment.
    Habert MO; Horn JF; Sarazin M; Lotterie JA; Puel M; Onen F; Zanca M; Portet F; Touchon J; Verny M; Mahieux F; Giron A; Fertil B; Dubois B
    Neurobiol Aging; 2011 Jan; 32(1):15-23. PubMed ID: 19250707
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A multi-institutional study of interobserver agreement in the evaluation of dementia with rCBF/SPET technetium-99m exametazime (HMPAO).
    Hellman RS; Tikofsky RS; Van Heertum R; Coade G; Carretta R; Hoffmann RG
    Eur J Nucl Med; 1994 Apr; 21(4):306-13. PubMed ID: 8005154
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison between cortical distribution of I-123 iomazenil and Tc-99m HMPAO in patients with Alzheimer's disease using SPECT.
    Varrone A; Soricelli A; Postiglione A; Salvatore M
    Clin Nucl Med; 1999 Sep; 24(9):660-5. PubMed ID: 10478740
    [TBL] [Abstract][Full Text] [Related]  

  • 25. SPECT brain perfusion abnormalities in mild or moderate traumatic brain injury.
    Abdel-Dayem HM; Abu-Judeh H; Kumar M; Atay S; Naddaf S; El-Zeftawy H; Luo JQ
    Clin Nucl Med; 1998 May; 23(5):309-17. PubMed ID: 9596157
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Regional cerebral blood flow in Parkinson's disease as an indicator of cognitive impairment.
    Derejko M; Sławek J; Wieczorek D; Brockhuis B; Dubaniewicz M; Lass P
    Nucl Med Commun; 2006 Dec; 27(12):945-51. PubMed ID: 17088679
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A study of regional cerebral blood flow and cognitive performance in Alzheimer's disease.
    O'Brien JT; Eagger S; Syed GM; Sahakian BJ; Levy R
    J Neurol Neurosurg Psychiatry; 1992 Dec; 55(12):1182-7. PubMed ID: 1479398
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cranial computed tomographic observations in multi-infarct dementia. A controlled study.
    Gorelick PB; Chatterjee A; Patel D; Flowerdew G; Dollear W; Taber J; Harris Y
    Stroke; 1992 Jun; 23(6):804-11. PubMed ID: 1595096
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Concordance between (99m)Tc-ECD SPECT and 18F-FDG PET interpretations in patients with cognitive disorders diagnosed according to NIA-AA criteria.
    Ito K; Shimano Y; Imabayashi E; Nakata Y; Omachi Y; Sato N; Arima K; Matsuda H
    Int J Geriatr Psychiatry; 2014 Oct; 29(10):1079-86. PubMed ID: 24687634
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neurospect in neurotoxic chemical exposure demonstration of long-term functional abnormalities.
    Heuser G; Mena I
    Toxicol Ind Health; 1998; 14(6):813-27. PubMed ID: 9891913
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Regional cerebral blood flow differences in patients with mild cognitive impairment between those who did and did not develop Alzheimer's disease.
    Park KW; Yoon HJ; Kang DY; Kim BC; Kim S; Kim JW
    Psychiatry Res; 2012; 203(2-3):201-6. PubMed ID: 22980226
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Brain perfusion follow-up in Alzheimer's patients during treatment with acetylcholinesterase inhibitors.
    Nobili F; Koulibaly M; Vitali P; Migneco O; Mariani G; Ebmeier K; Pupi A; Robert PH; Rodriguez G; Darcourt J
    J Nucl Med; 2002 Aug; 43(8):983-90. PubMed ID: 12163621
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vascular cognitive impairment in small vessel disease: clinical and neuropsychological features of lacunar state and Binswanger's disease.
    Ramos-Estebanez C; Moral-Arce I; Gonzalez-Mandly A; Dhagubatti V; Gonzalez-Macias J; Munoz R; Hernadez-Hernandez JL
    Age Ageing; 2011 Mar; 40(2):175-80. PubMed ID: 21239411
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tc-99m HMPAO brain perfusion SPECT in acute aphasia. Correlation with clinical and structural findings.
    Janicek MJ; Schwartz RB; Carvalho PA; Garada B; Holman BL
    Clin Nucl Med; 1993 Dec; 18(12):1032-8. PubMed ID: 8293621
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Regional cerebral blood flow study with 99mTc-hexamethyl-propyleneamine oxime single photon emission computed tomography in Alzheimer's and multi-infarct dementia.
    Battistin L; Pizzolato G; Dam M; Ponza I; Borsato N; Zanco PL; Ferlin G
    Eur Neurol; 1990; 30(5):296-301. PubMed ID: 2269322
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Discriminative use of SPECT in frontal lobe-type dementia versus (senile) dementia of the Alzheimer's type.
    Pickut BA; Saerens J; Mariën P; Borggreve F; Goeman J; Vandevivere J; Vervaet A; Dierckx R; de Deyn PP
    J Nucl Med; 1997 Jun; 38(6):929-34. PubMed ID: 9189144
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of [99mTc]HMPAO SPECT with [18F]fluoromethane PET in cerebrovascular disease.
    Heiss WD; Herholz K; Podreka I; Neubauer I; Pietrzyk U
    J Cereb Blood Flow Metab; 1990 Sep; 10(5):687-97. PubMed ID: 2384541
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Heterogeneity of neocortical cerebral blood flow deficits in dementia of the Alzheimer type: a [99mTc]-d,l-HMPAO SPECT study.
    Waldemar G; Bruhn P; Kristensen M; Johnsen A; Paulson OB; Lassen NA
    J Neurol Neurosurg Psychiatry; 1994 Mar; 57(3):285-95. PubMed ID: 8158175
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Single photon emission computerised tomography in elderly patients with Alzheimer's disease and multi-infarct dementia. Regional uptake of technetium-labelled HMPAO related to clinical measurements.
    McKeith IG; Bartholomew PH; Irvine EM; Cook J; Adams R; Simpson AE
    Br J Psychiatry; 1993 Nov; 163():597-603. PubMed ID: 8298827
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Technetium HMPAO SPECT study in dementia with Lewy bodies, Alzheimer's disease and idiopathic Parkinson's disease.
    Defebvre LJ; Leduc V; Duhamel A; Lecouffe P; Pasquier F; Lamy-Lhullier C; Steinling M; Destée A
    J Nucl Med; 1999 Jun; 40(6):956-62. PubMed ID: 10452310
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.